HCA Healthcare (HCA) Stock
Key stats
- Market cap
- $101.85B
- Price / Earnings ratio
- 14.6x
- EPS (TTM)
- $30.23
- Volume
- Loading
- 52-week high
- $556.52
- 52-week low
- $353.99
- Dividend yield
- 0.65%
- Dividend amount (latest)
- $0.78
- EPS vs analyst estimate
- +22.1%Q3 FY25 · $6.96 vs $5.70
- Next earnings report
- 23 Oct 2026
Source: third-party data provider, as of October 16, 2026
EPS estimate: analyst consensus
Compare with HCA
Recent news

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
HCA

HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA

HCA Healthcare Presents 2026 Awards of Distinction
HCA Healthcare Presents 2026 Awards of Distinction
HCA

Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
HCA
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 73.79
- MACD 12/26/9
- 10.45
- EMA 9 of MACD
- 7.11
- MACD histogram
- 3.34
- SMA 50
- $424.31
- Price above SMA 50
- EMA 50
- $427.10
- Price above EMA 50
- SMA 200
- $445.02
- Price above SMA 200
- EMA 200
- $444.62
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 14, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 15 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $7.18 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
Take the Zacks Approach to Beat the Markets: HF Sinclair, Accenture & FirstCash in Focus
HCA

HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call
HCA

HCA Healthcare Presents 2026 Awards of Distinction
HCA Healthcare Presents 2026 Awards of Distinction
HCA

Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
Can Shorter Hospital Stays Help HCA Handle More Patient Demand?
HCA

Can HCA Sustain Earnings Growth Despite a Changing Service Mix?
Can HCA Sustain Earnings Growth Despite a Changing Service Mix?
HCA

HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook
HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook
HCA

HCA Healthcare Completes Acquisition of the College of Health Care Professions
HCA Healthcare Completes Acquisition of the College of Health Care Professions
HCA

MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare
MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare
HCA

‘Big Short' Michael Burry just updated his portfolio for September
‘Big Short' Michael Burry just updated his portfolio for September
HCA

Can Operational Resiliency Protect HCA's Long-Term Profitability?
Can Operational Resiliency Protect HCA's Long-Term Profitability?
HCA
News tone: automated (AI) classification of the article's content, not a price prediction.
About HCA Healthcare
HCA Healthcare, Inc. owns and operates 185 hospitals and approximately 2,000 sites of care, including surgery centers, free standing emergency rooms, urgent care centers and physician clinics in 21 states and the United Kingdom. We are dedicated to providing healthcare services that meet each community's local healthcare needs. We seek to integrate various services to deliver patient care with maximum quality and efficiency.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Samuel N. Hazen | CEO & Director | 1960 |
| Mr. Michael A. Marks | CFO & Executive VP | 1970 |
| Mr. Jon Mack Foster | Executive VP & COO | 1962 |
| Mr. Michael R. McAlevey | Executive VP and Chief Legal & Administrative Officer | 1964 |
| Dr. Michael S. Cuffe M.B.A., M.D. | Executive Officer | 1966 |
| Dr. Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus | 1939 |
| Mr. Christopher F. Wyatt | Senior VP, Principal Accounting Officer & Controller | 1978 |
| Mr. Chad J. Wasserman | Senior VP & Chief Information Officer | — |
| Mr. Frank George Morgan C.F.A. | Vice President of Investor Relations | — |
| Ms. Wendy Warren | Senior VP and Chief Ethics & Compliance Officer | — |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of October 16, 2026
Technical indicators
- RSI 14
- 73.79
- MACD 12/26/9
- 10.45
- EMA 9 of MACD
- 7.11
- MACD histogram
- 3.34
- SMA 50
- $424.31
- Price above SMA 50
- EMA 50
- $427.10
- Price above EMA 50
- SMA 200
- $445.02
- Price above SMA 200
- EMA 200
- $444.62
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 14, 2026. Technical data, not a recommendation.
Analyst views
15 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $380.00
- Average
- $457.53
- High
- $579.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | +1.6 | -10.1 | +13.9 | |||||||||
| 2022 | -5.5 | +5.5 | -0.7 | -14.4 | -0.2 | -18.8 | +21.3 | -6.2 | -7.9 | +12.5 | +8.6 | +0.6 |
| 2023 | +4.9 | -6.9 | +7.9 | +8.8 | -7.0 | +13.3 | -8.3 | +1.3 | -12.4 | -8.5 | +11.1 | +7.3 |
| 2024 | +10.7 | -0.9 | +6.9 | -6.1 | +9.8 | -3.4 | +15.2 | +8.9 | +2.7 | -11.5 | -8.4 | -8.4 |
| 2025 | +10.8 | -8.4 | +11.0 | -0.2 | +11.2 | +0.2 | -9.1 | +13.2 | +4.9 | +7.9 | +10.1 | -7.2 |
| 2026 | +3.8 | +6.6 | -11.2 | -8.5 | -12.6 | +5.1 | +2.4 | +1.9 | +3.2 | +11.1 |
Corporate actions
Upcoming
No upcoming corporate actions for HCA



